BOULDER, Colo., January 15, 2004 -- /PRNewswire-FirstCall/ -- ENCISION INC. (OTC Bulletin Board:ECSN) today announced that its common stock has been approved for trading on the American Stock Exchange (AMEX). The stock is expected to start trading on the AMEX during the week of January 19, 2004 under the new trading symbol ECI.

"We are pleased to announce that Encision stock will soon begin trading on the American Stock Exchange, a move that will provide Encision shareholders with many advantages, including the benefits of a larger, more orderly trading environment," said James A. Bowman, Encision's President & CEO.

"Our move to the American Stock Exchange is another milestone in our Company's development and emergence in the marketplace," added Mr. Bowman. "We appreciate this opportunity to become part of the AMEX trading community."

Encision's securities currently trade on the OTC Bulletin Board under the symbol ECSN where it will trade prior to transferring to the American Stock Exchange during the week of January 19, 2004. A listing on AMEX means that Encision securities may not be subject to restrictions inherent with being traded on the OTCBB, including restrictions imposed by certain brokerage houses on the ability of their brokers to solicit orders or recommend stocks that trade on the OTCBB. With the move to this major national exchange, the Company may attract a broader investor base and institutional investment interest.

Encision was approved for listing on the AMEX based upon a review by an Exchange Listing Qualifications Panel which authorized approval of the listing pursuant to Section 1203(c) of the AMEX Company Guide; notwithstanding the fact that the Company does not fully satisfy the Exchange's regular initial listing standards, and with respect to the Exchange's Standard 2, does not fully satisfy market value of public float and stockholder's equity. The Panel's decision was based upon its determination that Encision satisfies the minimum Alternative Listing Standards and the affirmative finding that mitigating factors warrant listing pursuant to the Alternative Listing Standards. The Listing Qualifications Panel was specifically impressed with the Company's recent financial results, the demonstration of sound management and the substantial market for the Company's unique, patented products.

Encision Inc. designs and manufactures innovative surgical devices that allow the surgeon to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM® Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.

The authorization for listing on AMEX is contingent upon the Company's compliance with the requirements of Alternative Listing Standard B, set forth in Section 1203(c) of the AMEX Company Guide, at the time it begins trading on the Exchange.

In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to increase revenues through the Company's distribution channels, insufficient quantity of new account conversions, insufficient cash to fund operations, scale up production to meet delivery obligations and other factors discussed in the Company's filings with the Securities and Exchange Commission.

For further information please contact:
Marcia McHaffie
Controller
Encision Inc.
303-444-2600 x101